87 results
8-K
ARTH
Arch Therapeutics, Inc.
15 Nov 23
Entry into a Material Definitive Agreement
4:47pm
requirement and the requirement of the Company to achieve its listing in connection with a firm commitment underwritten public offering.
The closing
DEF 14C
a8pkv64wwm p9925du
1 Sep 23
Information statement
4:30pm
8-K
EX-10.1
ribulnx48zfhsc0 x6u8
23 Aug 23
Departure of Directors or Certain Officers
8:30am
PRE 14C
6nxa8 awd4k
22 Aug 23
Preliminary information
4:52pm
8-K
EX-10.1
wh6jj5 bp
24 Jul 23
Departure of Directors or Certain Officers
4:32pm
424B4
9140qkxatd1
30 Aug 22
Prospectus supplement with pricing info
5:21pm
424B3
va5pp
11 Jul 22
Prospectus supplement
5:25pm
424B3
ul76g5bteb85b3g
11 Jul 22
Prospectus supplement
5:24pm
424B3
v7gpw z354rkyj
11 Jul 22
Prospectus supplement
5:24pm
8-K
EX-10.1
muk9pzu wn3dbzl
8 Jul 22
Entry into a Material Definitive Agreement
6:03am
POS AM
iu60ozu5wljjw7dj
22 Dec 21
Prospectus update (post-effective amendment)
4:05pm
424B3
dt1zebxrkd8kqjjn
6 May 21
Prospectus supplement
12:59pm